Developing a Lipid-Based System for Co-delivery of a Vaccine and Adjuvants

University of British Columbia and Amgen British Columbia (ABC) will collaborate to develop a safe and efficient lipid-based vaccine delivery system that can be used in laboratory animals to enhance the production of specific antibodies against difficult targets. These antibodies can be further screened and characterized for treating various diseases in humans.

Faculty Supervisor:

Shyh-Dar Li

Student:

Partner:

Amgen British Columbia

Discipline:

Life Sciences

Sector:

Health and Related Sciences & Technology; Pharmaceuticals; Biotechnology

University:

The University of British Columbia

Program:

Accelerate

Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects